| [1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA-A: A Cancer Journal for Clinicians,2021,71(3):209−249.
|
| [2] |
XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022:profiles, trends, and determinants[J]. Chinese Medical Journal,2022,135(5):584−590.
|
| [3] |
ZHANG Y, TAN L X, LI C, et al. Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by dss[J]. AMB Express,2020,10(1):119−127.
|
| [4] |
IAHTISHAM-UL-HAQ, KHAN S, AWAN K A, et al. Sulforaphane as a potential remedy against cancer:Comprehensive mechanistic review[J]. Journal of Food Biochemistry,2021,46(3):e13886.
|
| [5] |
AUNE D, GIOVANNUCCI E, BOFFETTA P, et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies[J]. International Journal of Epidemiology,2017,46(3):1029−1056.
|
| [6] |
CHENG L, WAN K, LIANG H, et al. Sulforaphane and sulforaphane[A]. Glucosinolates:Properties, Recovery, and Applications, 2020, 281−232.
|
| [7] |
SINHA S, SHARMA S, SHARMA A, et al. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of tnbcs via down regulation of sirtuins-mediated emt signaling axis[J]. Phytomedicine,2021,84:153492.
|
| [8] |
VANDUCHOVA A, ANZENBACHER P, ANZENBACHEROVA E. Isothiocyanate from broccoli, sulforaphane, and its properties[J]. Journal of Medicinal Food,2018,22(2):121−126.
|
| [9] |
DINKOVA-KOSTOVA A T, FAHEY J W, KOSTOV R V, et al. KEAP1 and Done? targeting the NRF2 pathway with sulforaphane[J]. Trends in Food Science & Technology, 2017, 69(Pt B):257−269.
|
| [10] |
JAMES D, DEVARAJ S, BELLUR P, et al. Novel concepts of broccoli sulforaphanes and disease:induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli[J]. Nutrition Reviews,2012,70(11):654−665.
|
| [11] |
MAHN A, CASTILLO A. Potential of sulforaphane as a natural immune system enhancer:A review[J]. Molecules,2021,26(3):752−783.
|
| [12] |
SE-RAN J, CHEEMA A, BOSE C, et al. Multi-omic analysis reveals the anti-aging impact of sulforaphane on the microbiome and metabolome[J]. ResearchGate, 2020.
|
| [13] |
LI Z S, LIU Y M, FANG Z Y, et al. Natural sulforaphane from broccoli seeds against influenza a virus replication in mdck cells[J]. Natural Product Communications, 2019, 14(6):1934578X1985822.
|
| [14] |
AXELSSON A S, TUBBS E, MECHAM B, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes[J]. Science Translational Medicine,2017,9(394):eaah4477.
|
| [15] |
JAYAKUMAR T, CHEN W F, LU W J, et al. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase:ex vivo and in vivo studies[J]. The Journal of Nutritional Biochemistry,2013,24(6):1086−1095.
|
| [16] |
JAKUBIKOVA J, CERVI D, OOI M, et al. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma[J]. Haematologica,2011,96(8):1170−1179.
|
| [17] |
MILCZAREK M, POGORZELSKA A, WIKTORSKA K. Synergistic interaction between 5-fu and an analog of sulforaphane-2-oxohexyl isothiocyanate-in an in vitro colon cancer model[J]. Molecules,2021,26(10):3019−3032. doi: 10.3390/molecules26103019
|
| [18] |
WANG Y, WU H Z, DONG N N, et al. Sulforaphane induces s-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells[J]. Scientific Reports,2021,11(1):2504. doi: 10.1038/s41598-021-81815-2
|
| [19] |
YI H X, LI Z M, LIU X X, et al. Therapeutic mechanism of lapatinib combined with sulforaphane on gastric cancer[J]. Evidence-Based Complementary and Alternative Medicine,2021,eCAM:9933274.
|
| [20] |
KAN S F, WANG J, SUN G X. Sulforaphane regulates apoptosis-and proliferation related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer[J]. International Journal of Molecular Medicine,2018,42(5):2447−2458.
|
| [21] |
JAMASBI E, HAMELIAN M, HOSSAIN M A, et al. The cell cycle, cancer development and therapy[J]. Mol Biol Rep. 2022, 49(11):10875−10883.
|
| [22] |
BLOOM J, CROSS F R. Multiple levels of cyclin specificity in cell-cycle control[J]. Molecular Cell Biology,2007,8(2):149−160.
|
| [23] |
MATTHEWS H K, BERTOLI C, DE BRUIN RAM. Cell cycle control in cancer[J]. Nature Reviews Molecular Cell Biology,2021,23(1):74−88.
|
| [24] |
LAPENNA S, GIORDANO A. Cell cycle kinases as therapeutic targets for cancer[J]. Nature Reviews Drug Discovery,2009,8(7):547−566.
|
| [25] |
HUANG B, LEI S X, WANG D, et al. Sulforaphane exerts anticancer effects on human liver cancer cells via induction of apoptosis and inhibition of migration and invasion by targeting MAPK7 signalling pathway[J]. Journal of BUON,2020,25(2):959−964.
|
| [26] |
MENG W, MENG J, ZHANG F, et al. Sulforaphane overcomes t790m-mediated gefitinib resistance in vitro through epithelial-mesenchymal transition[J]. Journal of Physiology and Pharmacology,2021,72(5):741−749.
|
| [27] |
WANG L P, TIAN Z F, YANG Q, et al. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway[J]. Oncotarget,2015,6(28):25917−25931. doi: 10.18632/oncotarget.4542
|
| [28] |
TOMASELLO B, DOMENICA M, DI M, et al. Rapha myr, a blend of sulforaphane and myrosinase, exerts antitumor and anoikis- sensitizing effects on human astrocytoma cells modulating sirtuins and dna methylation[J]. International Journal of Molecular Sciences,2020,21(15):5328−5353. doi: 10.3390/ijms21155328
|
| [29] |
王凡平, 乔彩娟, 孙彦威, 等. 莱菔硫烷诱导急性髓系白血病KG1a和KG1细胞G2/M期阻滞的作用和相关机制[J]. 中国实验血液学杂志,2021,29(4):1050−1055. [WANG F P, QIAO C J, SUN Y W, et al. Effect and mechanism of sulforaphane on G2/ M phase arrest of acute Myeloid Leukemia KG1a and KG1 Cells[J]. Journal of Experimental Hematology,2021,29(4):1050−1055.]
WANG F P, QIAO C J, SUN Y W, et al. Effect and mechanism of sulforaphane on G2/ M phase arrest of acute Myeloid Leukemia KG1a and KG1 Cells[J]. Journal of Experimental Hematology, 2021, 29（4）: 1050−1055.
|
| [30] |
SUSKI J M, BRAUN M, STRMISKA V, et al. Targeting cell-cycle machinery in cancer[J]. Cancer Cell,2021,39(6):759−778. doi: 10.1016/j.ccell.2021.03.010
|
| [31] |
ROYSTON K J, PAUL B, NOZELL S, et al. Withaferin a and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms[J]. Experimental Cell Research,2018,368(1):67−74. doi: 10.1016/j.yexcr.2018.04.015
|
| [32] |
DAVIS F M, STEWART T A, THOMPSON E W, et al. Targeting emt in cancer:opportunities for pharmacological intervention[J]. Trends in Pharmacological Sciences,2014,35(9):479−488. doi: 10.1016/j.tips.2014.06.006
|
| [33] |
LI C L, YAN Z, PENG X H, et al. Sulforaphane inhibits invasion via activating erk1/2 signaling in human glioblastoma u87mg and u373mg cells[J]. PLoS One,2014,9(2):e90520. doi: 10.1371/journal.pone.0090520
|
| [34] |
LIN J S, XU Y L, ZHAO X, et al. Anticancer activity of sulforaphane against human hepatoblastoma cells involves apoptosis, autophagy and inhibition ofβ-catenin signaling pathway[J]. Archives of Medical Science,2020(1):1−9.
|
| [35] |
谢金芳, 曹春雨, 任雪, 等. SFN对小鼠乳腺癌4T1细胞上皮-间质转化, 增殖和迁移的影响研究[J]. 中国癌症杂志,2021,31(7):605−615. [XIE J F, CAO C Y, REN X, et al. Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells[J]. China Oncology,2021,31(7):605−615.]
XIE J F, CAO C Y, REN X, et al. Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells[J]. China Oncology, 2021, 31（7）: 605−615.
|
| [36] |
HAN S C, WANG Z, LIU J N, et al. Mir-29a-3p-dependent col3a1 and col5a1 expression reduction assists sulforaphane to inhibit gastric cancer progression[J]. Biochemical Pharmacology,2021,188:114539. doi: 10.1016/j.bcp.2021.114539
|
| [37] |
ALHAZMI N, PAI C P, ALBAQAMI A, et al. The promyelocytic leukemia protein isoform pml1 is an oncoprotein and a direct target of the antioxidant sulforaphane (sfn)[J]. Biochimica ET Biophysica Acta-Molecular Cell Research,2020,1867(8):118707. doi: 10.1016/j.bbamcr.2020.118707
|
| [38] |
EZEKA G, ADHIKARY G, KANDASAMY S, et al. Sulforaphane inhibits prmt5 and mep50 function to suppress the mesothelioma cancer cell phenotype[J]. Molecular Carcinogenesis,2021,60(7):429−439. doi: 10.1002/mc.23301
|
| [39] |
SIMÕES B M, SANTIAGO-GÓMEZ A, CHIODO C, et al. Targeting stat3 signaling using stabilised sulforaphane (sfx-01) inhibits endocrine resistant stem-like cells in er-positive breast cancer[J]. Oncogene,2020,39(25):4896−4908. doi: 10.1038/s41388-020-1335-z
|
| [40] |
VERMEULEN K, BOCKSTAELE D R, BERNEMAN Z N. Apoptosis:mechanisms and relevance in cancer[J]. Annals of Hematology,2005,84(10):627−639. doi: 10.1007/s00277-005-1065-x
|
| [41] |
PENG F, LIAO M R, et al. Regulated cell death (rcd) in cancer:key pathways and targeted therapies[J]. Signal Transduction and Targeted Therapy,2022,7(1):286−352. doi: 10.1038/s41392-022-01110-y
|
| [42] |
GROSS A, MCDONNELL J M, KORSMEYER S J. Bcl-2 family members and the mitochondria in apoptosis[J]. Genes & Development,1999,13(15):1899−1911.
|
| [43] |
LU Z M, REN Y D, YANG L, et al. Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting Nrf2 in esophageal squamous cell carcinoma[J]. Acta Pharmaceutica Sinica,2020,11(5):1246−1260.
|
| [44] |
顾文燕, 李丽, 吴敏. SFN通过调节Bax表达降低结肠癌细胞株5-氟尿嘧啶的耐药[J]. 中国现代中药,2019,21(4):458−463. [GU W Y, LI L, WU M. Effect of sulforaphane on decrease of drug resistance of colon cancer cells to 5-fu via regulating bax expression[J]. Modern Chinese Medicine,2019,21(4):458−463.]
GU W Y, LI L, WU M. Effect of sulforaphane on decrease of drug resistance of colon cancer cells to 5-fu via regulating bax expression[J]. Modern Chinese Medicine, 2019, 21（4）: 458−463.
|
| [45] |
MOSS S F, BLASER M J. Mechanisms of disease:Inflammation and the origins of cancer[J]. Nature Clinical Practice Oncology,2005,2(2):90−97,113. doi: 10.1038/ncponc0081
|
| [46] |
CANDIDO J, HAGEMANN T. Cancer-related inflammation[J]. Journal of Clinical Immunology,2013,33(1):79−84.
|
| [47] |
SIM H, LEE W, CHOO S, et al. Sulforaphane alleviates particulate matter-induced oxidative stress in human retinal pigment epithelial cells[J]. Frontiers in Medicine,2021,8:685032. doi: 10.3389/fmed.2021.685032
|
| [48] |
BRYAN N B, DORFLEUTNER A, ROJANASAKUL Y, et al. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain[J]. Journal of Immunology,2009,182(5):3173−3182. doi: 10.4049/jimmunol.0802367
|
| [49] |
GALDIERO M R, MARONE G, MANTOVANI A. Cancer inflammation and cytokines[J]. Cold Spring Harbor Perspectives in Biology,2018,10(8):a028662. doi: 10.1101/cshperspect.a028662
|
| [50] |
PROPPER D J, BALKWILL F R. Harnessing cytokines and chemokines for cancer therapy[J]. Nature Reviews Clinical Oncology,2022,19(4):237−253. doi: 10.1038/s41571-021-00588-9
|
| [51] |
ZHU W, YU J B, NIE Y, et al. Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases[J]. Immunological Investigations,2014,43(7):638−652. doi: 10.3109/08820139.2014.909456
|
| [52] |
SUN Y Y, TANG J Q, LI C, et al. Sulforaphane attenuates dextran sodium sulphate induced intestinal inflammation via IL-10/stat3 signaling mediated macrophage phenotype switching[J]. Food Science and Human Wellness,2022,11(1):129−142. doi: 10.1016/j.fshw.2021.07.014
|
| [53] |
LOZANO-ONDOUA A N, SYMONS-LIGUORI A M, VANDERAH T W. Cancer-induced bone pain:mechanisms and models[J]. Neuroscience Letters, 2013, 557(pt A):52−59.
|
| [54] |
FU J, XU M, XU L S, et al. Sulforaphane alleviates hyperalgesia and enhances analgesic potency of morphine in rats with cancer-induced bone pain[J]. European Journal of Pharmacology,2021,909:174412. doi: 10.1016/j.ejphar.2021.174412
|
| [55] |
WHITE J P. IL-6, cancer and cachexia:Metabolic dysfunction creates the perfect storm[J]. Translation Cancer Research,2017,6(S2):S280−S285. doi: 10.21037/tcr.2017.03.52
|
| [56] |
AL-BAKHEIT A, ABU-QATOUSEH L. Sulforaphane from broccoli attenuates inflammatory hepcidin by reducing IL-6 secretion in human HepG2 cells[J]. Journal of Functional Foods,2020,75(2020):1−7.
|
| [57] |
FREUND A, CHAUVEAU C, BROUILLET J P, et al. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells[J]. Oncogene,2003,22(2):256−265. doi: 10.1038/sj.onc.1206113
|
| [58] |
BUCK I, MORCEAU F, GRIGORAKAKI C, et al. Linking anemia to inflammation and cancer:The crucial role of TNF-α[J]. Biochemical Pharmacology,2008,77(10):1572−1579.
|
| [59] |
杨艳华, 梁丽琴. SFN对胃癌细胞生物学特征的影响及其机制研究[J]. 中国药师,2019,22(5):840−845. [YANG Y H, LIANG L Q. Effect of sulforaphane on biological activity of gastric cancer cells and underlying mechanisms[J]. Chinese Pharmacist,2019,22(5):840−845.]
YANG Y H, LIANG L Q. Effect of sulforaphane on biological activity of gastric cancer cells and underlying mechanisms[J]. Chinese Pharmacist, 2019, 22（5）: 840−845.
|
| [60] |
SPORN M B, LIBY K T. Nrf2 and cancer:the good, the bad and the importance of context[J]. Nature Reviews Cancer,2012,12(8):564−571. doi: 10.1038/nrc3278
|
| [61] |
CHEN W M, JIANG T, WANG H H, et al. Does Nrf2 contribute to p53-mediated control of cell survival and death?[J]. Antioxidants & Redox Signaling,2012,17(12):1670−1675.
|
| [62] |
GWON Y, OH J, KIM J S. Sulforaphane induces colorectal cancer cell proliferation through nrf2 activation in a p53-dependent manner[J]. Applied Biological Chemistry,2020,63(1):86−96. doi: 10.1186/s13765-020-00578-y
|
| [63] |
RONG Y, YUAN C H, QU Z, et al. Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing pge2[J]. Scientific Reports,2016,6(1):23824. doi: 10.1038/srep23824
|
| [64] |
RONG Y, HUANG L X, YI K Z, et al. Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells-sciencedirect[J]. Cancer Letter,2020,493:189−196. doi: 10.1016/j.canlet.2020.08.041
|
| [65] |
AHMED S M, LUO L, NAMANI A, et al. Nrf2 signaling pathway:pivotal roles in inflammation[J]. Biochimica et Biophysica Acta-Molecular Basis of Disease,2017,1863(2):585−597. doi: 10.1016/j.bbadis.2016.11.005
|
| [66] |
MPAB C, ECLB C, IA B, et al. Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway[J]. The Journal of Nutritional Biochemistry,2021,98:108817. doi: 10.1016/j.jnutbio.2021.108817
|
| [67] |
SANTOS P, MACHADO A, GRANDIS R D, et al. Effects of sulforaphane on the oxidative response, apoptosis, and the transcriptional profile of human stomach mucosa cells in vitro[J]. Genetic Toxicology and Environmental Mutagenesis,2020,854:503201.
|
| [68] |
LIN S B, GREGORY R I. MicroRNA biogenesis pathways in cancer[J]. Nature reviews Cancer,2015,15(6):321−333. doi: 10.1038/nrc3932
|
| [69] |
RUPAIMOOLE R, SLACK F J. MicroRNA therapeutics:towards a new era for the management of cancer and other diseases[J]. Nature Reviews Drug Discovery,2017,16(3):203−222. doi: 10.1038/nrd.2016.246
|
| [70] |
PENG Z T, GU P. Sulforaphane suppresses autophagy during the malignant progression of gastric carcinoma via activating miR-4521/PIK3R3 pathway[J]. Human & Experimental Toxicology,2021,40(12):S711−S720.
|
| [71] |
GEORGIKOU C, BUGLIONI L, BREMERICH M, et al. Novel broccoli sulforaphane-based analogues inhibit the progression of pancreatic cancer without side effects[J]. Biomolecules,2020,10(5):769−785. doi: 10.3390/biom10050769
|
| [72] |
CHENG T, CHEN J, HUANG X F, et al. CT1-3, a novel magnolol-sulforaphane hybrid suppresses tumorigenesis through inducing mitochondria-mediated apoptosis and inhibiting epithelial mesenchymal transition[J]. European Journal of Medicinal Chemistry,2020,199:112441. doi: 10.1016/j.ejmech.2020.112441
|
| [73] |
GASPARELLO J, GAMBARI L, PAPI C, et al. High levels of apoptosis are induced in the human colon cancer ht-29 cell line by co-administration of sulforaphane and a peptide nucleic acid targeting mir-15b-5p[J]. Nucleic Acid Therapeutics,2020,30(3):164−174. doi: 10.1089/nat.2019.0825
|
| [74] |
SANTANA-GÁLVEZ J, VILLELA-CASTREJÓN J, SERNA-SALDÍVAR S O, et al. Synergistic combinations of curcumin, sulforaphane, and dihydrocaffeic acid against human colon cancer cells[J]. International Journal of Molecular Sciences,2020,21(9):3108−3128. doi: 10.3390/ijms21093108
|
| [75] |
XU Y, HAN X Y, LI Y Y, et al. Sulforaphane mediates glutathione depletion via polymeric nanoparticles to restore cisplatin chemosensitivity[J]. ACS nano,2019,13(11):13445−13455. doi: 10.1021/acsnano.9b07032
|
| [76] |
GRECO G, SCHNEKENBURGER M, CATANZARO E, et al. Discovery of Sulforaphane as an inducer of ferroptosis in U-937 leukemia cells:expanding its anticancer potential[J]. Cancers (Basel),2021,14(1):76−92. doi: 10.3390/cancers14010076
|
| [77] |
AKIYOSHI S, KIKUCHI H, KURIBAYASHI F, et al. Sulforaphane displays the growth inhibition, cytotoxicity and enhancement of retinoic acid-induced superoxide-generating activity in human monoblastic U937 cells[J]. Fundamental Toxicological Sciences,2019,6(8):319−325. doi: 10.2131/fts.6.319
|
| [78] |
RORKE E A, ADHIKARY G, SZMACINSKI H, et al. Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity[J]. Molecular Carcinogenesis,2021,61(1):19−32.
|
| [79] |
XIA Y, KANG T W, JUNG D Y, et al. Sulforaphane inhibits nonmuscle invasive bladder cancer cells proliferation through suppression of hif-1 α-mediated glycolysis in hypoxia[J]. Journal of Agricultural and Food Chemistry,2019,67(28):7844−7854. doi: 10.1021/acs.jafc.9b03027
|
| [80] |
AMER M A, MOHAMED T R, RAHMAN R A A, et al. Studies on exogenous elicitors promotion of sulforaphane content in broccoli sprouts and its effect on the MDA-MB-231 breast cancer cell line[J]. Annals of Agricultural Sciences,2021,66(1):46−52. doi: 10.1016/j.aoas.2021.02.001
|
| [81] |
GU H F, REN F Z, MAO X Y, et al. Mineralized and GSH-responsive hyaluronic acid based nano-carriers for potentiating repressive effects of sulforaphane on breast cancer stem cells-like properties[J]. Carbohydrate Polymers,2021,269:118294−118305. doi: 10.1016/j.carbpol.2021.118294
|
DownLoad: